Dicyclomine for Gastritis: Limited Efficacy and Better Alternatives

Mechanism of Action and Indications

Dicyclomine is primarily indicated for gastrointestinal smooth muscle spasm, particularly in irritable bowel syndrome (IBS), not for gastritis, as stated by the American Gastroenterological Association 1, 2

No clinical guidelines recommend dicyclomine for gastritis management, according to the American College of Gastroenterology 3, 4
Gastritis treatment should focus on addressing the underlying cause, such as H. pylori infection, NSAIDs, or alcohol, rather than symptom management with antispasmodics, as recommended by the National Comprehensive Cancer Network 5

For gastritis, proton pump inhibitors and histamine-2 (H2) receptor antagonists are the recommended treatments to reduce gastric acid production, as suggested by the National Comprehensive Cancer Network 5
For nausea and vomiting associated with gastritis, dopamine receptor antagonists are more appropriate than antispasmodics, according to the National Comprehensive Cancer Network 5
For abdominal pain in gastritis, acid-suppressive drugs are first-line treatments rather than antispasmodics, as stated by the American Gastroenterological Association 6

Dicyclomine is effective for treating abdominal pain associated with IBS, as reported by the Gut journal 3
It has demonstrated efficacy for gastrointestinal smooth muscle spasm, according to the American College of Gastroenterology 2

Common adverse effects of dicyclomine include dry mouth, visual disturbance, and dizziness, as noted by the Gut journal and the American College of Gastroenterology 3, 2
Anticholinergic effects may worsen constipation, limiting its use in constipation-predominant conditions, as stated by the American College of Gastroenterology 2

For functional abdominal pain, neuromodulators like tricyclic antidepressants and serotonin-norepinephrine reuptake inhibitors may be more effective, as suggested by the Clinical Gastroenterology and Hepatology journal 7
For gastroparesis-related symptoms, prokinetics like metoclopramide may be more appropriate than antispasmodics, according to the Clinical Gastroenterology and Hepatology journal 7